List of SBIR/STTR awards granted to Hillhurst Biopharmaceuticals, Inc.

List of SBIR/STTR awards granted to Hillhurst Biopharmaceuticals, Inc.

List of SBIR/STTR awards granted to MEDICAL DIRECTIONS, INC.

List of SBIR/STTR awards granted to SNAKE CREEK LASERS LLC

List of SBIR/STTR awards granted to Analatom

List of funding rounds for Ethopass, LLC

List of Biotium patents

where

SBIR/STTR Award Recipient

is

‌

Hillhurst Biopharmaceuticals, Inc.

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ Hillhurst Biopharmaceuticals, Inc. STTR Phase I Award, September 2021	A STTR Phase I contract was awarded to Hillhurst Biopharmaceuticals, Inc. in September, 2021 for $453,158.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Hillhurst Biopharmaceuticals, Inc.		National Institutes of Health	STTR	1R41NS122576-01	Phase I	453,158	September 20, 2021	sbir.gov/node/2187591
	‌ Hillhurst Biopharmaceuticals, Inc. STTR Phase I Award, August 2020	A STTR Phase I contract was awarded to Hillhurst Biopharmaceuticals, Inc. in August, 2020 for $222,338.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Hillhurst Biopharmaceuticals, Inc.		National Institutes of Health	STTR	1R41HL150889-01A1	Phase I	222,338	August 15, 2020	sbir.gov/node/1911015
	‌ Hillhurst Biopharmaceuticals, Inc. STTR Phase I Award, August 2022	A STTR Phase I contract was awarded to Hillhurst Biopharmaceuticals, Inc. in August, 2022 for $299,894.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Hillhurst Biopharmaceuticals, Inc.		National Institutes of Health	STTR	1R41AI164948-01A1	Phase I	299,894	August 11, 2022	sbir.gov/node/2300435
	‌ Hillhurst Biopharmaceuticals, Inc. SBIR Phase II Award, September 2018	A SBIR Phase II contract was awarded to Hillhurst Biopharmaceuticals, Inc. in September, 2018 for $1,972,708.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Hillhurst Biopharmaceuticals, Inc.		National Institutes of Health	SBIR	2R44HL131065-03A1	Phase II	1,972,708	September 20, 2018	sbir.gov/node/1573649
	‌ Hillhurst Biopharmaceuticals, Inc. SBIR Phase I Award, April 2018	A SBIR Phase I contract was awarded to Hillhurst Biopharmaceuticals, Inc. in April, 2018 for $224,940.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Hillhurst Biopharmaceuticals, Inc.		National Institutes of Health	SBIR	1R43GM125430-01A1	Phase I	224,940	April 1, 2018	sbir.gov/node/1567385
	‌ Hillhurst Biopharmaceuticals, Inc. STTR Phase I Award, September 2021	A STTR Phase I contract was awarded to Hillhurst Biopharmaceuticals, Inc. in September, 2021 for $299,899.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Hillhurst Biopharmaceuticals, Inc.		National Institutes of Health	STTR	1R41EY033264-01	Phase I	299,899	September 1, 2021	sbir.gov/node/2190471
	‌ Hillhurst Biopharmaceuticals, Inc. STTR Phase I Award, May 2020	A STTR Phase I contract was awarded to Hillhurst Biopharmaceuticals, Inc. in May, 2020 for $219,112.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Hillhurst Biopharmaceuticals, Inc.		National Institutes of Health	STTR	1R41DK123933-01A1	Phase I	219,112	May 16, 2020	sbir.gov/node/1911037
	‌ Hillhurst Biopharmaceuticals, Inc. SBIR Phase I Award, September 2015	A SBIR Phase I contract was awarded to Hillhurst Biopharmaceuticals, Inc. in September, 2015 for $699,340.0 USD from the U.S. Department of Health & Human Services.	‌ Hillhurst Biopharmaceuticals, Inc.			SBIR	1R43NS093677-01	Phase I	699,340	September 15, 2015	sbir.gov/node/1045819
	‌ Hillhurst Biopharmaceuticals, Inc. SBIR Phase I Award, April 2016	A SBIR Phase I contract was awarded to Hillhurst Biopharmaceuticals, Inc. in April, 2016 for $299,808.0 USD from the U.S. Department of Health & Human Services.	‌ Hillhurst Biopharmaceuticals, Inc.			SBIR	1R43HL131065-01A1	Phase I	299,808	April 7, 2016	sbir.gov/node/1164387
	‌ Hillhurst Biopharmaceuticals, Inc. SBIR Phase II Award, August 2016	A SBIR Phase II contract was awarded to Hillhurst Biopharmaceuticals, Inc. in August, 2016 for $1,497,651.0 USD from the U.S. Department of Health & Human Services.	‌ Hillhurst Biopharmaceuticals, Inc.			SBIR	1R44DK111260-01	Phase II	1,497,651	August 15, 2016	sbir.gov/node/1199003
	‌ Hillhurst Biopharmaceuticals, Inc. SBIR Phase II Award, April 2023	A SBIR Phase II contract was awarded to Hillhurst Biopharmaceuticals, Inc. in April, 2023 for $999,578.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Hillhurst Biopharmaceuticals, Inc.		National Institutes of Health	SBIR	2R44HL131065-05	Phase II	999,578	April 1, 2023	sbir.gov/node/2506811

11 results

0 selected

11 results

0 selected